Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Epidemiology of erectile dysfunction

International Journal of Impotence Research volume 15, pages 63–71 (2003)Cite this article

Abstract

This review of the current epidemiological literature on erectile dysfunction (ED) suggests that approximately 5–20% of men have moderate-to-severe ED. Different definitions of ED, age distributions and concomitant medical conditions, as well as methodological differences, may explain much of the variance in reported prevalence rates. Various chronic disorders are associated with elevated rates of ED including depression, diabetes, and cardiovascular and neurological diseases. Such disorders are more common in the elderly, which may partially explain the elevated prevalence of ED in men over 60 y of age. Currently, up to 70% of men with ED are not treated. However, so many men experience considerable distress from their condition, that the increasing awareness of ED as well as the availability of noninvasive treatments may result in a greater proportion of patients seeking treatment, and eventually regaining satisfaction with their sex life.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Lewis R, Hatzichristou D, Lauman E, McKinley J . Epidemiological and natural history of erectile dysfunction; risk factors including iatrogenic and aging. In: Jardin A, Wagner G, Khoury S, Giuliano F, Padma-Nathan H, Rosen R (eds). Erectile Dysfunction. Plymbridge Distributors Ltd, Plymouth PL 6 7PY, United Kingdom, 2000, pp 19–51.

    Google Scholar 

  2. Simons JS, Carey MP . Prevalence of sexual dysfunctions: results from a decade of research. Arch Sex Behav 2001; 30: 177–219.

    Article  CAS  Google Scholar 

  3. NIH Consensus Development Panel on Impotence. Impotence. NIH Consensus Development Panel on Impotence. Am Med Assoc 1993; 270: 83–90.

  4. Krane RJ, Goldstein I, Saenz de Tejada I . Impotence. N Engl J Med 1989; 321: 1648–1659.

    Article  CAS  Google Scholar 

  5. Fugl-Meyer AR, Branholm IB, Fugl-Meyer KS . Happiness and domain-specific life satisfaction in adult northern Swedes. Clin Rehabili 1991; 5: 25–33.

    Article  Google Scholar 

  6. Fugl-Meyer AR, Lodnert G, Branholm IB, Fugl-Meyer KS . On life satisfaction in male erectile dysfunction. Int J Impot Res 1997; 9: 141–148.

    Article  CAS  Google Scholar 

  7. Fugl-Meyer KS . Chapter 12 Sex in Sweden: On the Swedish Sexual Life. The National Institute of Public Health. Stockholm, 1998, pp 218–234.

    Google Scholar 

  8. Fendrick AM . Access to innovative treatment of erectile dysfunction: clinical, economic, and quality-of-life considerations. Am J Manage Care 2000; 6 (Suppl 12): S632–S638.

    CAS  Google Scholar 

  9. Tan HL . Economic cost of male erectile dysfunction using a decision analytic model: for a hypothetical managed-care plan of 100,000 members. Pharmacoeconomics 2000; 17: 77–107.

    Article  CAS  Google Scholar 

  10. Stolk EA et al. Cost utility analysis of sildenafil compared with papaverine–phentolamine injections. BMJ 2000; 320: 1165–1168.

    Article  CAS  Google Scholar 

  11. Smith KJ, Roberts MS . The cost-effectiveness of sildenafil. Ann Intern Med 2000; 132: 933–937.

    Article  CAS  Google Scholar 

  12. Kinsey AC . Sexual Behaviour in the Human Male. W B Saunders: Philadelphia, 1948.

    Google Scholar 

  13. Spector IP, Carey MP . Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav 1990; 19: 389–408.

    Article  CAS  Google Scholar 

  14. Feldman HA et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.

    Article  CAS  Google Scholar 

  15. Rosen RC et al. The international index of erectile function (IIEF): a multidimensional scale for assessments of erectile dysfunction. Urology 1997; 49: 822–830.

    Article  CAS  Google Scholar 

  16. Fugl-Meyer AR, Fugl-Meyer K . Sexual disabilities, problems and satisfaction in 18–74 year old Swedes. Scand J Sexol 1999; 2: 79–105.

    Google Scholar 

  17. Béjin A . The epidemiology of premature ejaculation and of its association with erectile dysfunction. Adrologie 1999; 9: 211–225.

    Article  Google Scholar 

  18. Solstad K, Hertoft P . Frequency of sexual problems and sexual dysfunction in middle-aged Danish men. Arch Sex Behav 1993; 22: 51–58.

    Article  CAS  Google Scholar 

  19. Johannes CB et al. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol 2000; 163: 460–463.

    Article  CAS  Google Scholar 

  20. Ventegodt S . Sex and the quality of life in Denmark. Arch Sex Behav 1998; 27: 295–307.

    Article  CAS  Google Scholar 

  21. Kontula O, Haavio-Mannila E . Sexual Pleasures. Enhancement of Sex Life in Finland, 1971–1992. Dartmouth Publishing Company: Aldershot, 1995.

    Google Scholar 

  22. Malmsten UG, Milson I, Molander U, Norlen LJ . Urinary incontinence and lower urinary tract symptoms: an epidemiological study of men aged 45 to 99 years. J Urol 1997; 158: 1733–1737.

    Article  CAS  Google Scholar 

  23. Braun M et al. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res 2000; 12: 305–311.

    Article  CAS  Google Scholar 

  24. Braun M et al. KEED-erster deutschspraching validierter Fragebogen zur Erfassung der männlichen sexuallen Funktion. Aktuel Urol 1998; 29: 300–305.

    Article  Google Scholar 

  25. Meuleman EJ et al. Erectile dysfunction: prevalence and effect on the quality of life; Boxmeer study. Neder Tijdschr Geneesk 2001; 145: 576–581.

    CAS  Google Scholar 

  26. O'Leary MP et al. A brief sexual function inventory for urology. Urology 1995; 46: 697–706.

    Article  CAS  Google Scholar 

  27. Blanker MH et al. Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: prevalence, concern, and relation to sexual activity. Urology 2001; 57: 763–768.

    Article  CAS  Google Scholar 

  28. Virag R, Beck-Ardilly L . Nosology, epidemiology, clinical quantification of erectile dysfunction. La Revue Med Interne 1997; 18 (Suppl 1): 10s–13s.

    Article  Google Scholar 

  29. Martin-Morales A et al. Prevalence and independent risk factors for ereticle dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol 2001; 166: 569–575.

    Article  CAS  Google Scholar 

  30. Panser LA et al. Sexual function of men aged 40 to 79 years: the Olmsted County Study of urinary symptoms and health status among men. J Am Geriatri Soc 1995; 43: 1107–1111.

    Article  CAS  Google Scholar 

  31. Laumann EO, Paik A, Rosen RC . Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281: 537–544.

    Article  CAS  Google Scholar 

  32. Pinnock CB, Stapleton AM, Marshall VR . Erectile dysfunction in the community: a prevalence study. Med J Austr 1999; 171: 353–357.

    Article  CAS  Google Scholar 

  33. Ergen A et al. Prevalence and correlates of erectile dysfunction in Turkey. A population-based study. Poster presented at the ESIR Congress, 2001.

  34. Feldman HA et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 2000; 30: 328–338.

    Article  CAS  Google Scholar 

  35. Wabrek AJ, Burchell RC . Male sexual dysfunction associated with coronary heart disease. Arch Sex Behav 1980; 9: 69–75.

    Article  CAS  Google Scholar 

  36. Sjögren K, Fugl-Meyer AR . Some factors influencing quality of sexual life after myocardial infarction. Int Rehabil Med 1983; 5: 197–201.

    Article  Google Scholar 

  37. Diokno AC, Brown MB, Herzog AR . Sexual function in the elderly. Arch Intern Med 1990; 150: 197–200.

    Article  CAS  Google Scholar 

  38. Wei M et al. Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol 1994; 140: 930–937.

    Article  CAS  Google Scholar 

  39. Virag R, Bouilly P, Frydman D . Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985; 1: 181–184.

    Article  CAS  Google Scholar 

  40. Bruckert E, Giral P, Heshmati HM, Turpin G . Men treated with hypolipidaemic drugs complain more frequently of erectile dysfunction. J Clin Pharm Ther 1996; 21: 89–94.

    Article  CAS  Google Scholar 

  41. Weinhardt LS, Carey MP . Prevalence of erectile disorder among men with diabetes mellitus: comprehensive review, methodological critique, and suggestions for future research. J Sex Res 1996; 33: 205–214.

    Article  Google Scholar 

  42. Fedele D et al. Erectile dysfunction in diabetic subjects in Italy. Diabetes Care 1998; 21: 1973–1977.

    Article  CAS  Google Scholar 

  43. Lundberg PO et al. Neurosexology. Eur J Neurol 2001; 8 (Suppl 3): 2–24.

    Article  Google Scholar 

  44. Fugl-Meyer AR, Fugl-Meyer KS, Lundberg PO . Sexual rehabilitation. In: Frommelt P. Grötzbach (eds). Neurorehabilitation. Blackwell: Oxford, 1999, pp 370–388.

    Google Scholar 

  45. Elliott M, Biever LS . Head injury and sexual dysfunction. Brain Injury 1996; 10: 703–717.

    Article  CAS  Google Scholar 

  46. Lundberg PO et al. Neurological disorders: erectile and ejaculatory dysfunction. In: Jardin A, Wagner G, Khoury S et al (eds). Erectile Dysfunction. 1999, pp 591–646.

  47. Araujo AB et al. The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 1998; 60: 458–465.

    Article  CAS  Google Scholar 

  48. Mitchell JE, Popkin MK . Antidepressant drug therapy and sexual dysfunction in men: a review. J Clin Psychopharmacol 1983; 3: 76–79.

    Article  CAS  Google Scholar 

  49. Stanford JL et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 2000; 283: 354–360.

    Article  CAS  Google Scholar 

  50. Catalona WJ, Carvalhal GF, Mager DE, Smith DS . Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol 1999; 162: 433–438.

    Article  CAS  Google Scholar 

  51. Siegel T et al. The development of erectile dysfunction in men treated for prostate cancer. J Urol 2001; 165: 430–435.

    Article  CAS  Google Scholar 

  52. Leliefeld HHJ, Stoevelaar HJ, McDonnell J . Sexual function before and after various treatments for symptomatic benign prostatic hyperplasia. BJU Int 2002; 89: 208–213.

    Article  CAS  Google Scholar 

  53. Kunelius P, Häkkinen J, Lukkarinen O . Sexual functions in patients with benign prostatic hyperplasia before and after transurethral resection of the prostate. Urology Res 1998; 26: 7–9.

    Article  CAS  Google Scholar 

  54. Francisca EAE et al. Sexual function following high energy microwave thermotherapy: results of a randomized controlled study comparing transurethral microwave thermotherapy to transurethral prostatic resection. J Urol 1999; 161: 486–490.

    Article  CAS  Google Scholar 

  55. Mutscher R et al. Transurethral water-induced thermotherapy for the treatment of benign prostatic hyperplasia: a prospective multicenter clinical trial. J Urol 2000; 164: 1565–1569.

    Article  Google Scholar 

  56. Slag MF et al. Impotence in medical clinic outpatients. JAMA 1983; 249: 1736–1740.

    Article  CAS  Google Scholar 

  57. O'Keefe M, Hunt DK . Assessment and treatment of impotence. Med Clini North Am 1995; 79: 415–434.

    Article  CAS  Google Scholar 

  58. Derby CA, Barbour MM, Hume AL, McKinlay JB . Drug therapy and prevalence of erectile dysfunction in the Massachusetts Male Aging Study cohort. Pharmacotherapy 2001; 21: 676–683.

    Article  CAS  Google Scholar 

  59. Benet AE, Melman A . The epidemiology of erectile dysfunction. Urol Clini North Am 1995; 22: 699–709.

    CAS  Google Scholar 

  60. Kim YC et al. Endocrine and metabolic aspect in including treatment. In: Jardin A, Wagner G, Khoury S et al. (eds). Erectile Dysfunction, Plymbridge Distributor Ltd, Plymouth, United Kingdom, 1999; pp 205–240.

    Google Scholar 

  61. Rhoden EL et al. Is there any relation between serum levels of total testosterone and the severity of erectile dysfunction? Int J Impot Res 2002; 14: 167–171.

    Article  CAS  Google Scholar 

  62. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association, 1994.

  63. Fugl-Meyer KS, Fugl-Meyer AR . Sexual dysfunctions are not singularities. Int J Impot Res 2002. (Submitted).

  64. Morales A, Choi H, Giami A et al. Socio-cultural, educational and ethical aspects of erectile dysfunction. In: Jardin A, Wagner G, Khoury S et al. (eds). Erectile Dysfunction, Plymbridge Distributor Ltd, Plymouth, United Kingdom, 1999; pp 575–590.

    Google Scholar 

  65. Ansong KS, Lewis C, Jenkins P, Bell J . Help-seeking decisions among men with impotence. Urology 1998; 52: 834–837.

    Article  CAS  Google Scholar 

  66. Chew KK et al. Erectile dysfunction in general medicine practice: prevalence and clinical correlates. Int J Impot Res 2000; 12: 41–45.

    Article  CAS  Google Scholar 

  67. Alonso Sandoica E et al. Impotence in diabetics: its prevalence and social-health implications. Atención Primaria 1997; 20: 435–439.

    CAS  PubMed  Google Scholar 

  68. Skaer TL, Sclar DA, Robinson LM, Galin RS . Trends in the rate of self-report and diagnosis of ereticle dysfunction in the United States 1990–1998. Dis Manage Health Outcomes 2001; 9: 33–41.

    Article  Google Scholar 

Download references

Acknowledgements

This review was supported by a nonrestricted grant from Bayer AG.

Author information

Authors and Affiliations

  1. Bayer AG, Pharma Research Centre, Wuppertal, Germany

    M Kubin

  2. Division of Sexual Physiology, Rigshospitalet, Copenhagen, Denmark

    G Wagner

  3. Department of Neuroscience, Rehabilitation Medicine, University of Uppsala, Sweden

    A R Fugl-Meyer

Authors
  1. M Kubin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G Wagner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A R Fugl-Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Kubin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kubin, M., Wagner, G. & Fugl-Meyer, A. Epidemiology of erectile dysfunction. Int J Impot Res 15, 63–71 (2003). https://doi.org/10.1038/sj.ijir.3900949

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3900949

Keywords

This article is cited by

Search

Advanced search

Quick links